Insider · CIK 0001674905

Nelson Sonja

Reports to the SEC for 4 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001674905

Forms 4 and 5

Insider transactions

41 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-03-07	Ambrx Biopharma, Inc.Option to Purchase Common StockD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−60.7K sh	—	—	0
2024-03-07	Ambrx Biopharma, Inc.Restricted Stock UnitsD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−107K sh	—	—	0
2024-03-07	Ambrx Biopharma, Inc.Restricted Stock UnitsD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−50K sh	—	—	0
2024-03-07	Ambrx Biopharma, Inc.Option to Purchase Common StockD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−368K sh	—	—	0
2024-03-07	Ambrx Biopharma, Inc.Option to Purchase Common StockD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−121K sh	—	—	0
2024-03-07	Ambrx Biopharma, Inc.Option to Purchase Common StockD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−55.6K sh	—	—	0
2024-03-07	Ambrx Biopharma, Inc.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−22.9K sh	—	—	0
2024-03-05	Motus GI Holdings, Inc.Stock Option (right to buy)A Award	Director	AAward	+23.2K sh	—	—	23,205
2023-12-11	Ambrx Biopharma, Inc.A Award	Chief Financial Officer	AAward	+50K sh	—	—	545,776
2023-10-27	Ambrx Biopharma, Inc.S Sale	Chief Financial Officer	SSale	−12.8K sh	$9.82	−$125K	130,079
2023-07-05	Ambrx Biopharma Cayman, Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+389K sh	—	—	389,000
2023-04-26	Ambrx Biopharma Cayman, Inc.A Award	Chief Financial Officer	AAward	+1M sh	—	—	1,000,000
2023-01-27	Ambrx Biopharma Cayman, Inc.Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+2.57M sh	—	—	2,574,596
2023-01-27	Ambrx Biopharma Cayman, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−2.57M sh	—	—	0
2023-01-27	Ambrx Biopharma Cayman, Inc.Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+425K sh	—	—	425,000
2023-01-27	Ambrx Biopharma Cayman, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−425K sh	—	—	0
2023-01-27	Ambrx Biopharma Cayman, Inc.Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+850K sh	—	—	850,000
2023-01-27	Ambrx Biopharma Cayman, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−850K sh	—	—	0
2022-02-10	Motus GI Holdings, Inc.Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2022-01-05	Motus GI Holdings, Inc.A Award	Director	AAward	+82.5K sh	—	—	100,709
2021-06-22	Motus GI Holdings, Inc.Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2021-06-22	Motus GI Holdings, Inc.A Award	Director	AAward	+18.2K sh	—	—	18,209
2021-01-12	IBRXImmunityBio, Inc.S Sale	Chief Financial Officer	SSale	−16.4K sh	$15.00	−$245K	15,410
2021-01-12	IBRXImmunityBio, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−11.4K sh	—	—	165,907
2021-01-12	IBRXImmunityBio, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+11.4K sh	$3.07	+$34.9K	31,774
2021-01-04	IBRXImmunityBio, Inc.S Sale	Chief Financial Officer	SSale	−39.3K sh	$13.62	−$535K	20,410
2021-01-04	IBRXImmunityBio, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+22.7K sh	$3.07	+$69.8K	59,681
2021-01-04	IBRXImmunityBio, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−22.7K sh	—	—	177,271
2020-08-02	IBRXImmunityBio, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−10K sh	—	—	20,000
2020-08-02	IBRXImmunityBio, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−3,458 sh	$11.18	−$38.7K	36,952
2020-08-02	IBRXImmunityBio, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+10K sh	—	—	40,410
2020-03-23	IBRXImmunityBio, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+15K sh	—	—	36,542
2020-03-23	IBRXImmunityBio, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−6,132 sh	$2.82	−$17.3K	30,410
2020-03-23	IBRXImmunityBio, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−15K sh	—	—	0
2019-08-02	IBRXImmunityBio, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+10K sh	—	—	25,000
2019-08-02	IBRXImmunityBio, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−10K sh	—	—	30,000
2019-08-02	IBRXImmunityBio, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−3,458 sh	$1.27	−$4,391.66	21,542
2018-08-27	IBRXImmunityBio, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+200K sh	—	—	200,000
2018-08-02	IBRXImmunityBio, Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+40K sh	—	—	40,000
2018-03-23	IBRXImmunityBio, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+15K sh	—	—	15,000
2018-03-23	IBRXImmunityBio, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−15K sh	—	—	15,000

Recent filings

Accepted (ET)
Mar 134
Nelson Sonja0001493152-24-009772
SEC(opens sec.gov)
Mar 74
Nelson Sonja0000950170-24-028182
SEC(opens sec.gov)
Dec 114
Nelson Sonja0000950170-23-069447
SEC(opens sec.gov)
Oct 314
Nelson Sonja0000950170-23-056944
SEC(opens sec.gov)
Jul 74
Nelson Sonja0000950170-23-032230
SEC(opens sec.gov)
Apr 284
Nelson Sonja0001209191-23-026101
SEC(opens sec.gov)
Jan 314
Nelson Sonja0001209191-23-005791
SEC(opens sec.gov)
Feb 114
Nelson Sonja0001493152-22-004051
SEC(opens sec.gov)
Jan 74
Nelson Sonja0001493152-22-000691
SEC(opens sec.gov)

Companies

Address

C/O NANTKWEST, INC. 3530 JOHN HOPKINS COURT

SAN DIEGO, CA, 92121